{"timestamp": 1771603043.8822324, "value": {"ticker": "ATYR", "company_name": "aTyr Pharma, Inc.", "short_name": "aTyr Pharma, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 101141800, "float_shares": 95532069, "shares_outstanding": 97986634, "short_ratio": 9.57, "short_percent_of_float": 0.2494, "shares_short": 20432971, "shares_short_prior": 25013857, "insider_percent_held": 0.01435, "institution_percent_held": 0.55087, "total_cash": 90202000, "total_debt": 12359000, "total_revenue": 190000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": -140.76317, "debt_to_equity": 15.44, "current_ratio": 5.933, "book_value": 0.819, "price_to_book": 1.2603174, "operating_cashflow": -62922000, "free_cashflow": -34649876, "price": 1.0322, "52w_high": 7.29, "52w_low": 0.64, "avg_volume": 2286298, "avg_volume_10d": 2370750, "full_time_employees": 56, "audit_risk": 6, "overall_risk": 7}}